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Smoking is a common problem in both developed and developing countries, including in Indonesia. Based on a survey by the Tobacco Atlas in 2015, Indonesia has the highest number of smokers in Asia, with 66% of men in Indonesia being active smokers 1 . Smoking can lead to addiction owing to the nicotine contents, and harm due to the presence of toxic compounds such as carbon monoxide, ammonia and tar contents in tobacco 1 . Substances in cigarettes can also contribute for the occurrence of oral candidiasis, infection of in the mouth cavity caused by the fungus Candida albicans 2 . This fungus is part of the normal flora of the human mouth, but it can become pathogenic in certain conditions, for example, due to nicotine exposure 3 .
The C. albicans that infects human tissues generally form biofilm 3 , an extracellular matrix consisting of C. albicans colonies 4 . The size of the biofilm increases when the fungus was exposed to substances in cigarette smoke because cigarette contains chemicals that can initiate the growth of and nourish C. albicans 5, 6 .
Currently, fluconazole and nystatin are the most effective drugs for treating oral candidiasis. Unfortunately, these drugs could result in undesired side effects. Prolonged use of fluconazole, for example, can leads to resistance 7 whereas high dosages of nystatin give gastrointestinal discomfort and increase plaque formation 8 . Therefore, plant-derived antifungals may be a viable oral treatment option for candidiasis. One of these potential plants is Gracilaria verrucosa. This seaweed contains several bioactive compounds, including alkaloids, flavonoids, phenolics, saponins, steroids and terpenoids 9 . Aceh Province, Indonesia, has large G. verrucosa resources, although this aquatic plant has not been commonly used for medicinal purposes. Hence, the objective of the present study was to examine the ability of seaweed extract to inhibit the biofilm formation of C. albicans isolated from the saliva of smoker.
Methods

Time and site
The study was conducted in August 2017 at the Laboratory of Microbiology, Veterinary Faculty, Syiah Kuala University. The G. verrucosa seaweeds were collected from a farmer in Pulo Aceh, Aceh Province.
Ethics
All research protocols used in this study were approved by the Research Ethics Committee of the Dentistry Faculty of Syiah Kuala University No. 1741/UN11.1.21/TU/2017.
Saliva collection
The saliva was collected from an active smoker who worked as administrative staff at the Faculty of Dentistry Medicine of Syiah Kuala University and voluntarily participated in this study after completing informed consent. Inclusion criterion of the volunteer was active smoker who smoked 20 cigarettes per day. Saliva was collected once by spitting into a glass jar (15 ml) right after the subject finished smoking, and added with 10 ml of PBS (0.01 M, pH 7.2). The jar was centrifuged at 10,000 rpm for 10 minutes. The precipitate was stored for the microbiological examination.
Candida albicans isolation and preparation
Precipitate was cultured in ChromAgar Candida medium and incubated at 37°C for 2 days. The C. albicans fungus grew as green colonies. One colony of C. albicans was mixed with 5 ml of peptone in a tube and incubated at 37°C for 24 hours. Turbidity of medium was compared to a 0.5 McFarland solution standard, which was equivalent to 1.5 × 10 8 CFU/ml.
Seaweed extraction
Seaweed extraction was performed based by maceration using 96% methanol 10 . In brief, a total of 500 g of fresh seaweeds were washed with tap water then with distilled water. Seaweed samples were at 25°C for 24 hours, chopped into small pieces (2 mm), and soaked in 1. Tannin/phenolic test. Two drops of 1% FeCl 3 was added to 1 ml seaweed extract. The change in the color to a blackish green indicated the presence of tannin/phenolic 12 .
Amendments from Version 2
Revisions, corrections and details addition have been done throughout the manuscript as a response to the last comments/ questions of reviewers. Significant improvements made are including an explanation about the reasons why fluconazole 0.31 mg/ml did not show good antimycotic properties as expected.
References supported this explanation were also provided. Some parts of this explanation also answers a question from reviewer about the reason for determining dose of fluconazole. Correction and enrichment in methods were also performed to provide better clarity and readability. The method used was a modification of those previously used by two different researchers in analyzing biofilm formation by bacteria. Further details, especially those related to the low respondent involved, could not be made because research presented was still in the preliminary stage. 
See referee reports
REVISED
Data analysis
The data obtained were subjected to Kruskal-Wallis test using SPSS software v20.0 for windows.
Results
The results of phytochemical tests in Table 1 show that methanol extract of seaweed G. verrucosa contained bioactive compounds belonged to steroids, terpenoids, and tannins/polyphenols.
In general, the inhibitory effect was reduced as seaweed concentration increased (Figure 1 ). The highest inhibition after 24 and 48 hours time exposures was recorded from C. albicans culture treated with 25% seaweed extract, followed by those with 50% and 75%. The best inhibition after 75 hours time exposure, however, was found in C. albicans culture treated with 25% seaweed extract. In all time exposures, the inhibitory effect caused by fluconazole (control) was the worst, followed by those caused by 100% seaweed extracts, but there was no difference between these two groups. Results of Kruskal-Wallis analysis showed that seaweed extract significantly (p<0.05) inhibited the formation of biofilm by C. albicans, indicated potential of the extract to inhibit the growth of the fungus. 
Discussion
The study showed that 25-75% seaweed extracts are promising for inhibiting the growth of C. albicans as shown by much lower biofilm formation after 24, 48 and 72 hours exposure compared to those caused by positive control (fluconazole) and 100% seaweed extract. This indicated potential of seaweed extract as natural anti-fungus to treat oral candidiosis caused by against C. albicans in smokers.
C. albicans is a normal micro-organism in the human mouth. This fungus, however, can be pathogenic in certain circumstances 3 such as in the mouth of smokers 2 . Smoking can stimulate synthesis of HWP1, EAP1 and SAP2 proteins in C. albicans, causing higher virulence of the fungus. This can lead to increased formation of biofilm and finally cause oral candidiasis 6 . Smoking also cause a decreased immune function, making individuals more susceptible to oral infections, including candidiasis 4,6 .
The low effectiveness of fluconazole 0.31 µg/ml, the leading choice of therapy against C. albicans, against this fungus was probably caused by several factors such as low therapeutic dose and resistance of the fungus to the drug. Pfaller et al., who Fluconazole dose of 0.31 µg/ml used in this study was slightly higher than minimum dose ideally used to test antifungal resistance of the antifungal. This also meant that C. albicans strain isolated from smoker respondent involved in this study already developed resistance to the dose used. Increasing resistance of C. albicans against this fluconazole, one of the most azole antimycotics have been reported 18, 19 . This resistance, that is assumed related to prolonged or repeated exposure to low-dose of the antifungus 20 , must be confirmed by further study.
The stronger ability of 25-75% seaweed extracts to inhibit the formation of C. albicans biofilm significantly compared to those of fluconazole (positive control) was probably caused by bioactive compound presence in the extracts. These included steroids, terpenoids, and tannins/polyphenols, all of which have been known their benefit for human health. According to Sampaio et al. 21 , antifungal activity of a substance strongly depends on the composition of its bioactive compounds. Steroids can kill C. albicans through their lypophilic properties, interfering with the formation of fungal spores and mycelium 22 . This activity weakens C. albicans, inhibiting the formation of the biofilm. To function optimally, steroids require oligosaccharides that are also present in the seaweed content 23
Terpenoids are derivatives of saponins that may act as an antifungals by damaging organelles of the fungus and by inhibiting secretion of enzymes, leading to growth the inhibition C. albicans cells. Terpenoids can also damage the morphology of C. albicans 24 . Tannins may inhibit chitin synthesis in C. albicans cell walls, leading to lost of membrane cell protection and disrupted cellular metabolism. Tannins also can inhibit ergosteron activity of C. albicans 25 .
The effectiveness of seaweed extracts in inhibiting fungal growth is influenced by at least three factors, namely concentration, exposure time, and contact surface media 26 . The present study showed that diluted concentration (25-75%) of extracts showed better inhibitory effect on the growth of C. albicans than the more concentrated 100% extract. Concentrated extract usually has lesser effectiveness in vitro due to solubility and import problems. In more aqueous condition plant extracts generally show better medicinal properties with increased concentration as shown by a study testing antifungal activity of ethanol extracts of Syzygium jombolanum, Cassia siamea, Ordina wodier, Momodica charantia and Melia azedarach as well as two algal species Sargassum wightii and Saulerpa scalpellformis against 25 C. albicans isolates in vitro 27 .
This study also showed the best inhibitory effect of seaweed extracts was recorded at 24 hour of exposure. This is probably because the farnesol, a quorum-sensing molecule that has the potency to inhibit C. albicans growth 28 , works effectively after 48-72 hour of exposure.
This study, however, was still preliminary due to limited number of subject and unavailability of non-smoker, control. Virulence factor of C. albicans analyzed was also only biofilm formation. Since more virulence factors are possibly synthesized by the fungus under certain environmental condition, further studies are need to be conducted to investigate effect of individual bioactive compound contained in the seaweeds on the formation of biofilm and on the expression other virulence factors of C. albicans isolated form both smoker and non-smoker individuals.
Conclusion
Extract of Gracilaria verrucosa seaweed could inhibit the growth of C. albicans isolated from the saliva of a smoker. The inhibitory effect decrease with the increase of concentration, and reached the highest at concentration of 25% and time exposure of 24 hours.
Data availability
Dataset 1. The raw data of the Triplo anti-Biofilm seaweed to C. albicans for 24, 48 and 72 h at a wavelength 620 nm. DOI: 10.5256/f1000research.14879.d204270 29 .
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Introduction
The period "Smoking is a common problem in most developing countries, including Indonesia.". A reference should be added. Also, smoking is not a problem only or mainly in developing countries. Please, consider revising. The authors stated that "This fungus is part of the normal flora of the human mouth, but it can become pathogenic in certain conditions, for example, due to nicotine exposure.". The exposure to nicotine has been correlated with increasing in C. albicans virulence factor expression. The predisposing conditions for candidiasis are much more related to immunologic state of the host and imbalance in microflora. Please, consider revising. Revise the period "Infection with C. albicans will increase the formation of a biofilm of the fungus", it is confusing.
Revise the period "The biofilm is an extracellular matrix consisting of C. albicans colonies", it is confusing. The authors stated that "high dosages of nystatin give gastrointestinal discomfort and increase plaque formation". What do authors mean by "increase plaque formation"?
The rationale of the study is not clear. Why did the authors select G. verrucosa? Is this plant commonly used? Why did the authors decide to use saliva from a smoker individual?
Methods
Revise the period "C. albicans was extracted from the saliva", C. albicans was isolated from saliva. The authors reported that "G. verrucosa seaweed was collected from a farmer in Pulo Aceh, Aceh Province.". More information on the plant, the exact location it was collected from, the period of the year, identification procedure (how and who did the identification?), registration in herbarium, number of voucher should be included in the text. Please, revise the period "Saliva was collected by spitting into a glass jar (15 ml), then 1 ml PBS (0.01 M, pH 7.2) was added to the jar." Why did 1 ml of PBS added to the saliva? What was the final volume of saliva collected? Was saliva stimulated?
The authors stated that "If the colour of a colony was green, this indicated that the colony was C. albicans.". However, the color of the colony in CHROMagar is only a presumptive test and phenotypic or genotypic definitive identification should be done. The inclusion of a reference strain is highly needed.
Include the number of experiments/replicates performed.
The inclusion of more clinical isolates from non-smokers patients is needed.
The methodology of activity of extract on biofilm formation is not clear. Why and how peptone was removed from the wells? Why did the fungal suspension left in the wells for 5 min? How 100% extract concentration was obtained in the well (you already has the broth inside the well)? Why the concentration of 0.31 was chosen for fluconazole? Figure 1 should be revised. Note that optical density at 620 nm is higher after treatment with 100% extract when compared to the other concentrations.
Discussion and Conclusion sections should be revised after the revision of the aforementioned points.
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